(Q35798892)
Statements
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer (English)
L Vassilev
T Ranki
T Joensuu
E Jäger
J Karbach
C Wahle
K Partanen
K Kairemo
T Alanko
A Ristimäki
M Kankainen
A Hemminki
C Backman
M von Euler
E Haavisto
T Hakonen
J Juhila
M Jäderberg
P Priha
A Vuolanto
1 reference
1 reference